← All supplements
Strong evidenceHeart & metabolic

Red Yeast Rice

Red yeast rice genuinely lowers LDL cholesterol — because it contains monacolin K, which is chemically identical to the drug lovastatin. That also means it carries statin-like risks, with far worse dose standardisation than a prescription.

View on iHerb Ships to 180+ countries · welcome discount for new customers

What the science says

  • Lowers LDL cholesterol Strong evidence

    A 2023 systematic review and meta-analysis of randomised controlled trials found red yeast rice reduced LDL cholesterol by roughly 25-40 mg/dL (around 15-25%) versus placebo, alongside reductions in total cholesterol and triglycerides. The effect tracks the monacolin K content: products delivering 3-10 mg/day perform like a low-dose statin, and products with negligible monacolin do essentially nothing.

  • Alternative for people who cannot tolerate statins Moderate evidence

    Trials in statin-intolerant patients show meaningful LDL reduction with acceptable tolerability in many participants, which is why it is used clinically in this niche. But the mechanism is identical to a statin, so the pharmacological reason for intolerance often persists — real muscle symptoms and enzyme elevations are reported in pharmacovigilance data.

  • Reduces cardiovascular events Limited evidence

    The main outcome evidence is the Chinese Coronary Secondary Prevention Study using a specific Xuezhikang extract, which reported fewer coronary events. This has not been replicated with Western commercial supplements, and no supplement product on the market has demonstrated event reduction in its own right.

  • Product dose is unreliable Strong evidence

    Independent analyses have repeatedly found monacolin K content in commercial products varying by more than a hundredfold between brands, plus contamination with the nephrotoxic mycotoxin citrinin in some batches. You often cannot know what dose you are actually taking.

Dosage & safety

Studied doseTrials typically used extracts supplying 3-10 mg/day of monacolin K, usually with an evening meal. Since 2022, EU regulation caps monacolin K in food supplements at under 3 mg per daily dose and bans it for pregnant, breastfeeding and over-70 populations — European products are therefore weaker than those used in older trials. Effects on LDL appear within 4-8 weeks. Choose a product that states monacolin K content and tests for citrinin.
SafetyTreat this as a low-dose statin, not a gentle herb. Reported adverse effects mirror statins: myalgia, rarely rhabdomyolysis, and liver enzyme elevations including cases of hepatotoxicity — both documented in adverse event reporting system reviews. Contraindicated in pregnancy, breastfeeding, active liver disease, and alongside a prescription statin (additive risk). Serious interactions with CYP3A4 inhibitors: grapefruit juice, clarithromycin, itraconazole, ritonavir, cyclosporine, and with fibrates. Citrinin contamination is a real quality risk. Anyone taking it should have liver enzymes and, if symptomatic, creatine kinase checked, and should tell their doctor — many people take it without disclosing it because they consider it 'natural'.

How to take it

TimingWith the evening meal, as in the trials — cholesterol synthesis peaks overnight and monacolin K is short-acting.
With food?With food, which is how it was dosed and reduces stomach upset.
Worth knowingTell your doctor you take it and get liver enzymes checked; people routinely omit it from medication lists because they think of it as a herb.

Interactions

With medications

  • statins (atorvastatin, simvastatin and others)

    Monacolin K is chemically lovastatin, so the two are additive for muscle and liver toxicity. do not combine — treat red yeast rice as a statin dose

  • CYP3A4 inhibitors (clarithromycin, itraconazole, ritonavir, ciclosporin)

    These block monacolin K breakdown and can raise blood levels several-fold, risking rhabdomyolysis. do not combine without medical supervision

  • fibrates (gemfibrozil, fenofibrate)

    Additive risk of myopathy and rhabdomyolysis, as with a prescription statin. do not combine without medical supervision

With other supplements

  • berberine

    Berberine inhibits CYP3A4 and P-glycoprotein and can raise monacolin K exposure. avoid the combination or use only under medical supervision

  • high-dose niacin (above 1 g/day)

    Adds to the muscle toxicity risk seen when niacin is combined with statins. do not combine without medical supervision

Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.

Frequently asked questions

Does red yeast rice lower cholesterol?

Yes, with strong evidence: red yeast rice lowered LDL by roughly 15-25% in a 2023 meta-analysis, because its monacolin K is chemically identical to lovastatin. Products with negligible monacolin K do essentially nothing.

Is red yeast rice safer than a statin?

No: red yeast rice acts exactly like a low-dose statin, with reported muscle pain, rare rhabdomyolysis and liver toxicity, and its dose is far less reliable, varying more than a hundredfold between brands. Some batches have also contained the kidney toxin citrinin.

Can I take red yeast rice with a statin?

No: do not combine red yeast rice with a prescription statin, since the muscle and liver risks add up. Also avoid combining it with CYP3A4 inhibitors such as clarithromycin, itraconazole or ritonavir, fibrates, berberine or high-dose niacin without medical supervision.

How much red yeast rice should I take?

Trials used red yeast rice supplying 3-10 mg/day of monacolin K with the evening meal, though EU rules now cap supplements under 3 mg per day. Choose a product that states its monacolin K content and tests for citrinin, and tell your doctor you take it.

Scientific references

Where to buy

Jarrow Formulas, Red Yeast Rice + Co-Q10, 120 Veggie Capsules

Ships to 180+ countries · welcome discount for new customers

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic